This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Amir, R. E. Articles by Van den Veyver, I. B. Search for Related Content PubMed PubMed Citation Articles by Amir, R. E. Articles by Van den Veyver, I. B. Social Bookmarking                   What's this?

Newborn Screening and Prenatal Diagnosis for Rett Syndrome: Implications for Therapy

Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX

V. Reid Sutton, MD

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX

Ignatia B. Van den Veyver, MD

Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, iveyver{at}bcm.tmc.edu., Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX

Most girls with Rett syndrome develop normally prior to the appearance of the typical symptoms. A presymptomatic phase is also observed in many inborn errors of metabolism that are included in newborn screening programs. Diagnostic testing for mutations or large genomic rearrangements involving methyl-CpG binding protein 2 gene (MECP2) is highly sensitive and identifies mutations in up to 95% of female individuals with classic Rett syndrome. This has prompted some to ask whether MECP2 testing should be included in newborn and prenatal screening programs. We review current and evolving practices in these programs, emphasizing their relevance to Rett syndrome. The availability of a reliable test and the characteristic early latent phase, which creates a window of opportunity for early treatment, favor universal newborn screening for Rett syndrome. However, the high cost and the lack of an effective presymptomatic treatment make universal newborn screening for Rett syndrome impractical at present. In contrast, prenatal diagnosis should be offered to the parents of an affected child if the responsible mutation has been identified in the index case. (J Child Neurol 2005;20:779—783).

Journal of Child Neurology, Vol. 20, No. 9, 779-783 (2005)
DOI: 10.1177/08830738050200091401


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?